Stock REVB REVELATION BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Revelation Biosciences, Inc.

Equities

REVB

US76135L5075

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
2.107 USD -0.60% Intraday chart for Revelation Biosciences, Inc. +1.80% -85.97%
Mar. 22 Revelation Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Mar. 22 Revelation Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Revelation Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023
BU
Revelation Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)
BU
Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference
BU
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
BU
Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
CI
Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
BU
Revelation Biosciences : Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
PU
Thinking about buying stock in Meta Platforms, Ocular Therapeutix, Phathom Pharmaceuticals, Revelation Biosciences, or Sunworks?
PR
Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering
BU
Top Midday Decliners
MT
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday on Unchanged Fed Rate, Upcoming Earnings
MT
Top Premarket Decliners
MT
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
BU
Thinking about buying stock in Guardion Health Sciences, Minim, Revelation Biosciences, Nyxoah, or Pixelworks?
PR
Top Premarket Gainers
MT
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
BU
Top Premarket Gainers
MT
Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. REVB Stock
  4. News Revelation Biosciences, Inc.